G1 Therapeutics Ownership | Who Owns G1 Therapeutics?
G1 Therapeutics Ownership Summary
G1 Therapeutics is owned by 38.21% institutional investors, 10.92% insiders, and 50.86% retail investors. Blackrock is the largest institutional shareholder, holding 5.91% of GTHX shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 2.63% of its assets in G1 Therapeutics shares.
Institutional Shareholders
Top Institutional Shareholders by Total Shares
Holder | Shares | % Holding | Value |
---|---|---|---|
Blackrock | 3.08M | 5.91% | $7.03M |
Geode capital management | 1.08M | 2.07% | $2.46M |
State street | 827.96K | 1.59% | $1.89M |
D. e. shaw | 767.07K | 1.47% | $1.75M |
Jacobs levy equity management | 463.59K | 0.89% | $1.06M |
Morgan stanley | 401.48K | 0.77% | $915.38K |
Bridgeway capital management | 398.04K | 0.76% | $907.54K |
Boothbay fund management | 349.10K | 0.67% | $795.95K |
Two sigma investments, lp | 308.82K | 0.59% | $704.12K |
Two sigma advisers, lp | 211.70K | 0.41% | $482.68K |
Top Institutional Shareholders by % of Total Assets
Holder | Shares | % Assets | Value |
---|---|---|---|
Ikarian capital | 12.25K | 0.49% | $2.79M |
Bridgeway capital management | 398.04K | 0.02% | $907.54K |
Boothbay fund management | 349.10K | 0.02% | $795.95K |
Virtu financial | 74.35K | 0.01% | $170.00K |
Jacobs levy equity management | 463.59K | 0.00% | $1.06M |
Panagora asset management | 177.05K | 0.00% | $403.68K |
Two sigma investments, lp | 308.82K | 0.00% | $704.12K |
D. e. shaw | 767.07K | 0.00% | $1.75M |
Two sigma advisers, lp | 211.70K | 0.00% | $482.68K |
Geode capital management | 1.08M | 0.00% | $2.46M |
Top Buyers
Holder | Shares | % Assets | Change |
---|---|---|---|
Blackrock | 3.08M | 0.00% | 2.41M |
State street | 827.96K | 0.00% | 666.85K |
Geode capital management | 1.08M | 0.00% | 573.84K |
Boothbay fund management | 349.10K | 0.02% | 349.10K |
Morgan stanley | 401.48K | 0.00% | 226.14K |
Top Sellers
Holder | Shares | % Assets | Change |
---|---|---|---|
Vanguard group | - | - | -2.49M |
Woodline partners lp | - | - | -1.36M |
Renaissance | - | - | -1.25M |
Susquehanna group, llp | - | - | -950.84K |
Acadian asset management | - | - | -928.21K |
New Positions
Holder | Shares | % Assets | Change | Value |
---|---|---|---|---|
Boothbay fund management | 349.10K | 0.02% | 349.10K | $795.95K |
Panagora asset management | 177.05K | 0.00% | 177.05K | $403.68K |
Nuveen asset management | 66.93K | - | 66.93K | $152.60K |
Invesco | 35.71K | - | 35.71K | $81.42K |
Alliancebernstein | 22.34K | - | 22.34K | $50.94K |
Sold Out
Holder | Change |
---|---|
Newedge advisors | -200.00 |
Providence capital advisors | -212.00 |
Lazard asset management | -298.00 |
Planning capital management | -320.00 |
Farther finance advisors | -350.00 |
Institutional Ownership Trends
Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
---|---|---|---|---|---|---|---|---|---|---|
Jun 30, 2024 | 100 | 7.53% | 19,937,265 | 39.36% | 38 | 5.00% | 63 | 21.15% | 17 | 13.33% |
Mar 31, 2024 | 93 | 3.33% | 14,305,888 | 13.36% | 27 | 4.66% | 52 | 15.56% | 15 | -48.28% |
Dec 31, 2023 | 90 | 21.62% | 12,619,702 | 15.31% | 24 | 5.43% | 45 | 28.57% | 29 | 45.00% |
Sep 30, 2023 | 74 | -12.94% | 10,944,376 | -29.44% | 21 | 2.35% | 35 | 6.06% | 20 | -33.33% |
Jun 30, 2023 | 85 | -15.84% | 15,510,418 | -19.24% | 30 | 2.17% | 33 | -25.00% | 30 | -18.92% |
Top Mutual Funds Shareholders
Holder | Shares | % Holding | Change |
---|---|---|---|
Vanguard Total Stock Mkt Idx Inv | 1.39M | 2.63% | - |
Arbitrage R | 1.31M | 2.49% | 1.31M |
Vanguard Institutional Extnd Mkt Idx Tr | 659.13K | 1.25% | 594.00 |
Fidelity Canadian Large Cp Mlt Ast Bs O | 637.33K | 1.21% | 637.33K |
Fidelity Small Cap Index | 505.64K | 0.96% | -14.29K |
Fidelity Extended Market Index | 265.36K | 0.50% | 6.65K |
State St Russell Sm/Mid Cp® Indx NL Cl C | 263.37K | 0.50% | 61.62K |
Bridgeway Ultra-Small Company | 228.04K | 0.43% | 206.90K |
Vanguard Russell 2000 ETF | 198.71K | 0.38% | 5.00K |
AltShares Merger Arbitrage ETF | 170.38K | 0.32% | 170.38K |
Recent Insider Transactions
Date | Name | Role | Activity | Value |
---|---|---|---|---|
Jul 05, 2024 | Perry Andrew | Chief Commercial Officer | Sell | $3.35K |
Jul 05, 2024 | MURDOCK TERRY L | Chief Operating Officer | Sell | $6.21K |
Jul 05, 2024 | Malik Rajesh | Chief Medical Officer | Sell | $6.21K |
Jul 05, 2024 | Avagliano Mark | Chief Business Officer | Sell | $6.62K |
Jul 05, 2024 | Umstead John W. V | Chief Financial Officer | Sell | $1.32K |
Insider Transactions Trends
Date | Buy | Sell |
---|---|---|
2024 Q3 | - | 6 |
2024 Q2 | - | 7 |
2024 Q1 | - | 19 |
2023 Q4 | - | 2 |
2023 Q3 | - | 6 |
GTHX Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools